Skip directly to content

Referencias: Osteoartritis



Referencias en orden alfabético


AJ Kivitz, RW Moskowitz, E Woods, RC Hubbard, KM Verburg, JB Lefkowith, GS Geis. Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip. The Journal of International medical Research. 2001;97-124

http://imr.sagepub.com.proxy1.athensams.net/content/29/6/467.short


Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C,Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.Europe PubMend Central. 2013, 382(9894):769-779

http://europepmc.org/abstract/med/23726390


Chan Francis KL, Lanas Angel, Scheiman James, Berger Manuela F, Nguyen Ha, Goldstein Jay L. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. The Lancet . 2010; 173–179.

http://www.sciencedirect.com.proxy1.athensams.net/science/article/pii/S0140673610606733


Cheung Raymond, Krishnaswami Sriram, Kowalski Ken. Analgesic efficacy of celecoxib in postoperative oral surgery pain: A single-dose, two-center, randomized, double-blind, active- and placebo-controlled study. Clinical Therapeutics. 2007; 2498–2510.

http://www.sciencedirect.com.proxy1.athensams.net/science/article/pii/S0149291807003761


Cryer Byron, Li Chunming, Simon Lee S, Singh Gurkirpal, Stillman Martin J, Berger Manuela F. GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial. The American Journal of Gastroenterology. 2013; 108:392–400.

http://www.nature.com.proxy1.athensams.net/ajg/journal/v108/n3/abs/ajg2012467a.html


E Cardenas-Estrada, L G Oliveira, H L Abad, F Elayan, N Khalifa, T El-Husseini. Efficacy and Safety of Celecoxib in the Treatment of Acute Pain due to Ankle Sprain in a Latin American and Middle Eastern Population. The Journal International Medical Research. 2009; 97-124.

http://imr.sagepub.com.proxy1.athensams.net/content/37/6/1937.short<7


Emery Paul , Zeidler Henning , Kvien Tore K , Guslandi Mario , Naudin Raphael , Stead Helen, Verburg Kenneth M , Isakson Peter C, Hubbard Richard C , Geis Steven. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. The lacet. 1999; 2106–2111.

http://www.sciencedirect.com.proxy1.athensams.net/science/article/pii/S0140673699023326


H.-C. Diener, R. Schneider, R. Schneider. Per-capita consumption of analgesics: a nine-country survey over 20 years. The Journal of Headache and Pain. 2008; 225-231.

http://rd.springer.com.proxy1.athensams.net/article/10.1007/s10194-008-0046-6


Hoy Damian, March Lyn, Brooks Peter, Blyth Fiona, Woolf Anthony, Bain Christopher, Williams Gail, Smith Emma, Vos Theo, Barendregt Jan, Murray Chris, Burstein Roy, Buchbinder Rachelle. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases the Eular Journal. 2014; 73:968-974.

http://ard.bmj.com.proxy1.athensams.net/content/73/6/968.short

 


Leese Philip T, Hubbard Richard C, Aziz Karim, Isakson Peter C, Yu Shawn S. Steven Geis. Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial. The Journal Clinical Pharmacology. 2000; 124–132.

http://onlinelibrary.wiley.com.proxy1.athensams.net/doi/10.1177/00912700022008766/abstract


Mallen Sharon R, Essex Margaret N, Zhang Richard. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs. Current Medical Research & Opinion. 2011; 1359–136.

http://informahealthcare.com.proxy1.athensams.net/doi/abs/10.1185/03007995.2011.581274


Paresh Soni, Briton Shell, Gail Cawkwell, Chunming Li,Hong Ma. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.Current Medical Research y Opinion.2009; 1841-1851.

http://informahealthcare.com.proxy1.athensams.net/doi/abs/10.1185/03007990903018279


Petri Michelle , Hufman Stephen L , Waser Gregory , Snabes Harry Cui,Michael C , Verburg Kenneth M.Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. The Journal of Rheumatology. , 2004; 1614-1620.

http://www.jrheum.org.proxy1.athensams.net/content/31/8/1614.short


Schroer William C, Diesfeld Paul J, LeMarr Angela R, Reedy Mary E. Benefits of Prolonged Postoperative Cyclooxygenase-2 Inhibitor Administration on Total Knee Arthroplasty Recovery : A Double-Blind, Placebo-Controlled Study. The Journal of Arthroplasty. 2011; 2–7.

http://www.sciencedirect.com.proxy1.athensams.net/science/article/pii/S0883540311001665


Simon Lee S., Weaver Arthur L., Graham David Y., Kivitz Alan J., Lipsky Peter E., Hubbard Richard C., Isakson Peter C., Verburg Kenneth M., Yu Shawn S., Zhao William W. Geis Steven. Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis. The Journal of the American Medical Association. 1999; 282(20):1921-1928.

http://jama.jamanetwork.com.proxy1.athensams.net/article.aspx?articleid=192129


Strand Vibeke, Simon Lee S, Dougados Maxime, Sands George H, Bhadra Pritha, Breazna Aurora, Immitt Jeft. Treatment of Osteoarthritis with Continuous Versus Intermittent Celecoxib. The Journal Of Rheumatology. 2011 38(12):2501-2503;

http://www.jrheum.org.proxy1.athensams.net/content/38/12/2625.short


Whelton A, Lefkowith J L, West C R, Verburg K M. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Official Journal of the International Society of Nephrology. (2006) 70, 1495–1502.

http://www.nature.com.proxy1.athensams.net/ki/journal/v70/n8/abs/5001766a.html


White Paul F. , Sacan Ozlem, Tufanogullari Burcu , Eng Matthew, Nuangchamnong Nina , Ogunnaike Babatunde . Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Canadian Journal of Anesthesia. 2007; 342-348.

http://www.nature.com.proxy1.athensams.net/ki/journal/v70/n8/abs/5001766a.html


Wilner Keith D, Rushing Margaret, Walden Catherine, Adler Rebecca, Eskra James, Noveck Robert, Vargas Ramon. Celecoxib Does Not Affect the Antiplatelet Activity of Aspirin in Healthy Volunteers. The Journal Clinical Pharmacology.2013; 1027–1030.

http://onlinelibrary.wiley.com.proxy1.athensams.net/doi/10.1177/009127000204200910/abstract

 


Paresh Soni, Briton Shell, Gail Cawkwell, Chunming Li, Hong Ma, The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials,Informa Healthcare, August 2009, Vol. 25, No. 8 , Pages 1841-1851.

http://informahealthcare.com.proxy1.athensams.net/doi/abs/10.1185/03007990903018279


Dr. Philip T. Leese MD1, Dr. Richard C. Hubbard MD2, Dr. Aziz Karim PhD, FCP2,Dr. Peter C. Isakson PhD2, Dr. Shawn S. Yu PhD2 ,Dr. G. Steven Geis PhD, MD2,* Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial, The Journal of Clinical Pharmacology, Volume 40, Issue 2, pages 124–132, February 2000.

http://onlinelibrary.wiley.com.proxy1.athensams.net/doi/10.1177/00912700022008766/abstract


Paul F. White, Ozlem Sacan, Burcu Tufanogullari, Matthew Eng, Nina Nuangchamnong, Babatunde Ogunnaike, Effect of short-term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery, Canadian Journal of Anesthesia, May 2007, Volume 54, Issue 5, pp 342-348.

http://rd.springer.com.proxy1.athensams.net/article/10.1007/BF03022655


Efficacy and safety of celecoxib in the treatment of acute pain due to ankle sprain in a Latin American and Middle Eastern

http://imr.sagepub.com.proxy1.athensams.net/content/37/6/1937.short

Este material es de uso exclusivo para el cuerpo médico.
©Pfizer S.A.S Todos los derechos reservados – Prohibida su reproducción total o parcial sin autorización del titular.